ALLO
Price
$2.84
Change
-$0.25 (-8.09%)
Updated
Nov 12 closing price
105 days until earnings call
BEAM
Price
$27.94
Change
-$2.41 (-7.94%)
Updated
Nov 12 closing price
111 days until earnings call
Ad is loading...

ALLO vs BEAM

Header iconALLO vs BEAM Comparison
Open Charts ALLO vs BEAMBanner chart's image
Allogene Therapeutics
Price$2.84
Change-$0.25 (-8.09%)
Volume$2.28M
CapitalizationN/A
Beam Therapeutics
Price$27.94
Change-$2.41 (-7.94%)
Volume$1.59M
CapitalizationN/A
ALLO vs BEAM Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALLO vs. BEAM commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and BEAM is a Hold.

COMPARISON
Comparison
Nov 13, 2024
Stock price -- (ALLO: $2.84 vs. BEAM: $27.94)
Brand notoriety: ALLO and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 107% vs. BEAM: 158%
Market capitalization -- ALLO: $595.47M vs. BEAM: $2.31B
ALLO [@Biotechnology] is valued at $595.47M. BEAM’s [@Biotechnology] market capitalization is $2.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $492.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ALLO’s TA Score: 6 bullish, 3 bearish.
  • BEAM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than BEAM.

Price Growth

ALLO (@Biotechnology) experienced а -5.02% price change this week, while BEAM (@Biotechnology) price change was +16.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.29%. For the same industry, the average monthly price growth was +11.71%, and the average quarterly price growth was +7.79%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

BEAM is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+1.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.31B) has a higher market cap than ALLO($595M). BEAM YTD gains are higher at: 2.645 vs. ALLO (-11.526). BEAM has higher annual earnings (EBITDA): -162.88M vs. ALLO (-256.56M). BEAM has more cash in the bank: 1.01B vs. ALLO (445M). ALLO has less debt than BEAM: ALLO (87M) vs BEAM (165M). BEAM has higher revenues than ALLO: BEAM (353M) vs ALLO (65K).
ALLOBEAMALLO / BEAM
Capitalization595M2.31B26%
EBITDA-256.56M-162.88M158%
Gain YTD-11.5262.645-436%
P/E RatioN/AN/A-
Revenue65K353M0%
Total Cash445M1.01B44%
Total Debt87M165M53%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOBEAM
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 21 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMOCX17.53-0.07
-0.40%
Victory RS Mid Cap Growth C
OIEJX26.88-0.19
-0.70%
JPMorgan Equity Income R6
FVDFX38.41-0.31
-0.80%
Fidelity Value Discovery
CRRYX18.33-0.22
-1.19%
Columbia Small Cap Value II Inst3
FRNRX31.08-0.40
-1.27%
Franklin Natural Resources A